Live Breaking News & Updates on Kathrineg Mcgovern Medical School

Stay updated with breaking news from Kathrineg mcgovern medical school. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma


News Category Global Banking & Finance Reviews
UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma
UTHealth in Houston and Athersys Announce Commencement of Patient Enrollment in a Phase 2 Trial Evaluating MultiStem® Cell Therapy in Trauma
The University of Texas Health Science Center at Houston (UTHealth) and Athersys, Inc. (NASDAQ: ATHX) announced today that the first patient has been enrolled in a clinical study evaluating MultiStem
cell therapy for the potential early treatment of traumatic injuries and the subsequent complications that result. The MATRICS-1 (MultiStem Administration for Trauma Related Inflammation and Complications) study is being conducted at Memorial Hermann-Texas Medical Center, one of the busiest Level 1 trauma centers in the United States. ....

Memorial Hermann Hospital , United States , Texas Medical Center , University Of Texas , Karen Hunady , David Schull , Charless Cox Jr , Ivor Macleod , Robertw Mays , Uthealth Harris County Psychiatric Center , Armys Medical Research , Corporate Communications Investor Relations , Russo Partners , Multistem Administration For Trauma Related Inflammation , Kathrineg Mcgovern Medical School , Us Army , Harris Health Lyndonb Johnson Hospital , Centers For Disease Control , University Of Texas System Board Regents , Robert Cizik School Of Nursing , Ut Health Services , Memorial Hermann Foundation , Mcgovern Medical School , Technology Enterprise Consortium , Athersys Inc , Texas Health Science Center ,